In-Process Research and Development

Definition

In-process research and development (IPR&D) is a project acquired part-way through — bought as a standalone asset or picked up in a business combination — where the underlying work is incomplete at the acquisition date. Its treatment differs sharply from the same activity performed in-house, and the difference is a common source of confusion. Under IFRS, an IPR&D project acquired in a business combination is recognised as an intangible asset separately from goodwill at its acquisition-date fair value, because IFRS 3 treats it as identifiable and the reliable-measurement condition is taken to be satisfied. Expenditure on that project after the acquisition is then assessed as though it had been incurred internally: research-phase spend is written off under IAS 38.54, and development-phase spend is tested against the conditions in IAS 38.57. Worked example: a group acquires a business holding two unfinished platform projects. Both are recognised at fair value on acquisition, and the money spent after completion of the deal is split between research and development activity in the ordinary way. Jurisdiction contrast: US GAAP holds acquired IPR&D as an indefinite-lived intangible asset under ASC 350-30 until the project is completed or abandoned, while internally generated research and development is expensed under ASC 730. The judgement management makes is one of measurement — supporting the acquisition-date fair value, and then applying the phase boundary consistently to the spend that follows.

Taking a defensible position

The position

An in-process research and development project acquired in a business combination is recognised separately from goodwill at acquisition-date fair value under IFRS 3. Expenditure after the acquisition is treated as though incurred internally: research-phase costs are written off under IAS 38.54 and development-phase costs tested against IAS 38.57. Under US GAAP, acquired IPR&D is held as an indefinite-lived intangible under ASC 350-30 until completion or abandonment.

A defensible posture

The position a management team can defend rests on two records: a valuation of the acquired project a third party can follow, and a clear line marking where the acquired asset stops and post-acquisition spend begins. Continuing to carry everything spent on the project after the deal, on the basis that the asset itself was recognised, is the version most often challenged; assessing post-acquisition spend on its own terms is the stronger one.

Evidence to hold

Purchase price allocation working papers, with the method and inputs used to measure the acquired project at fair value.
The acquisition-date project record: stage reached, work remaining, and the expected route to completion.
Cost records separating post-acquisition spend from the acquired balance, project by project.
Impairment review documentation for any project carried while still incomplete.
A dated decision record for any project subsequently abandoned.

The challenge you may face

Expect the fair value to be tested first — the forecast behind it, the discount rate, and whether the project was genuinely identifiable at the acquisition date rather than part of goodwill. Reviewers then look at what happened afterwards: whether an incomplete project has been carried for several periods without an impairment review, and whether post-acquisition spend was assessed against the phase boundary or simply added to the acquired balance.

Complementary Terms

Concepts that frequently appear alongside In-Process Research and Development in practice.

IAS 38 (Intangible Assets)

The International Accounting Standard governing the recognition, measurement, and disclosure of intangible assets. IAS 38 requires that an intangible asset be identifiable, controlled by the entity, and expected to generate future economic benefits.

Development Costs (IAS 38)

Development costs are the expenditure incurred applying research findings to a plan or design for a new or substantially improved product, service, process or system before it enters commercial production or use. Under IAS 38 (IFRS — the default framework for UK groups reporting under adopted IFRS), the standard divides the work into two phases and treats them differently.

Research & Development (R&D)

Systematic investigation and experimentation aimed at creating new products, services, or processes, or significantly improving existing ones. R&D expenditure is one of the largest categories of intangible asset investment and is a key driver of innovation capital and future competitiveness.

Goodwill

An intangible asset that arises when a company is acquired for more than the fair value of its net identifiable assets. Goodwill reflects factors such as brand value, customer loyalty, workforce expertise, and synergies that are expected to generate future economic benefits.

Indefinite-Lived Intangible Asset

An intangible asset for which there is no foreseeable limit to the period over which it is expected to generate net cash inflows for the entity. Under IAS 38 and ASC 350, indefinite-lived intangible assets are not amortised but must be tested for impairment at least annually and whenever there is an indication of impairment.